Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nanni

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 19, 2006
18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumoursC Nanni, D Rubello, P Castellucci, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|August 13, 2013
Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of viewR Schiavina, E Brunocilla, M Borghesi, et al.
European Journal of Radiology|August 28, 2012
Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the diseaseP Spinnato, A Bazzocchi, A Brioli, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 30, 2013
Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131IC Pettinato, F Monari, C Nanni, et al.
Current Radiopharmaceuticals|April 20, 2013
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?R Schiavina, F Ceci, M Borghesi, et al.
European Review for Medical and Pharmacological Sciences|June 5, 2012
Biopsy for suspected spondylodiscitisA Gasbarrini, L Boriani, C Salvadori, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 22, 2007
Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method?D Rubello, C Nanni, I Merante Boschin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2007
68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumorsC Pettinato, A Sarnelli, M Di Donna, et al.
European Journal of Hybrid Imaging|May 22, 2018
Low dose radiation 18F-fluoride PET/CT in the assessment of Unilateral Condylar Hyperplasia of the mandible: preliminary results of a single centre experienceG M Lima, S Diodato, E Costabile, et al.
Anticancer Research|May 30, 2008
18F-FDG small animal PET for early detection of human anaplastic large cells lymphoma xenograft in immunocompromised miceV Ambrosini, C Quarta, P L Zinzani, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 19, 2006
18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumoursC Nanni, D Rubello, P Castellucci, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|August 13, 2013
Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of viewR Schiavina, E Brunocilla, M Borghesi, et al.
European Journal of Radiology|August 28, 2012
Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the diseaseP Spinnato, A Bazzocchi, A Brioli, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 30, 2013
Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131IC Pettinato, F Monari, C Nanni, et al.
Current Radiopharmaceuticals|April 20, 2013
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?R Schiavina, F Ceci, M Borghesi, et al.
European Review for Medical and Pharmacological Sciences|June 5, 2012
Biopsy for suspected spondylodiscitisA Gasbarrini, L Boriani, C Salvadori, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 22, 2007
Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method?D Rubello, C Nanni, I Merante Boschin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2007
68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumorsC Pettinato, A Sarnelli, M Di Donna, et al.
European Journal of Hybrid Imaging|May 22, 2018
Low dose radiation 18F-fluoride PET/CT in the assessment of Unilateral Condylar Hyperplasia of the mandible: preliminary results of a single centre experienceG M Lima, S Diodato, E Costabile, et al.
Anticancer Research|May 30, 2008
18F-FDG small animal PET for early detection of human anaplastic large cells lymphoma xenograft in immunocompromised miceV Ambrosini, C Quarta, P L Zinzani, et al.
Pageof 6